ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Scope & Guideline
Advancing the Future of Gastrointestinal Health
Introduction
Aims and Scopes
- Gastrointestinal and Liver Disease Research:
The journal covers a wide array of gastrointestinal and liver diseases, highlighting research on pathophysiology, diagnosis, and treatment options. - Pharmacotherapy and Treatment Strategies:
AP&T emphasizes the role of pharmacotherapy in managing gastrointestinal and liver diseases, including studies on drug efficacy, safety, and guidelines for clinical practice. - Emerging Therapies and Interventions:
The journal frequently publishes research on novel treatment modalities, including biologics, small molecules, and innovative therapies for various digestive disorders. - Clinical Guidelines and Best Practices:
AP&T aims to provide evidence-based recommendations for clinicians, focusing on improving patient outcomes in gastrointestinal and liver diseases. - Patient-Centered Outcomes and Quality of Life:
The journal addresses the importance of patient-reported outcomes, quality of life, and the psychosocial aspects of managing chronic digestive diseases. - Epidemiological Studies and Public Health:
Research related to the epidemiology of gastrointestinal and liver diseases, including risk factors, prevalence, and the impact of public health initiatives, is a key focus area. - Technology and Innovation in Gastroenterology:
AP&T explores advancements in diagnostic and therapeutic technologies, including the use of machine learning and non-invasive testing methods in gastroenterology.
Trending and Emerging
- Metabolic Dysfunction-Associated Liver Disease (MAFLD):
Research on MAFLD is increasingly prominent, focusing on its clinical implications, pathophysiology, and treatment strategies, reflecting a growing recognition of its significance. - Biologics and Targeted Therapies:
The use of biologics and targeted therapies for inflammatory bowel disease (IBD) and other gastrointestinal conditions is a rapidly expanding area of research, with a focus on optimizing treatment regimens. - Artificial Intelligence and Machine Learning:
The application of AI and machine learning in predicting disease outcomes and personalizing treatment approaches is a growing trend, indicating a shift towards data-driven medicine. - Patient-Centered Care and Quality of Life:
There is an increasing emphasis on research that evaluates patient-reported outcomes and quality of life in the context of gastrointestinal diseases, aligning with broader trends in healthcare. - Public Health and Epidemiology:
Studies addressing the epidemiology of liver diseases and gastrointestinal disorders, as well as public health interventions, are gaining traction, reflecting an awareness of the societal impact of these conditions. - Gut Microbiome Research:
The exploration of the gut microbiome’s role in health and disease, particularly in IBD and liver diseases, is an emerging theme, highlighting its significance in therapeutic strategies. - Long-term Outcomes of Chronic Diseases:
Research focusing on the long-term outcomes of chronic gastrointestinal and liver diseases, including the impact of treatment on disease progression and survival, is becoming increasingly important.
Declining or Waning
- Traditional Dietary Interventions:
Research focusing solely on traditional dietary interventions for gastrointestinal diseases has seen reduced emphasis, as newer therapies and pharmacological approaches gain prominence. - Basic Science without Clinical Relevance:
Studies that do not translate into clinical applications or lack direct relevance to patient care are being published less frequently, as the journal prioritizes clinically impactful research. - Single-Center Studies:
There is a noticeable decline in the publication of single-center studies, with a shift towards multi-center and larger cohort studies that yield more generalizable results. - Isolated Pathophysiological Mechanisms:
Research focusing solely on isolated mechanisms of disease without exploring therapeutic implications or clinical outcomes is diminishing, reflecting a preference for integrated approaches. - Non-Pharmacological Treatments:
There appears to be a waning interest in non-pharmacological treatments for digestive diseases, as the journal increasingly emphasizes pharmacotherapy and innovative drug treatments.
Similar Journals
Korean Journal of Gastroenterology
Fostering Global Dialogue on Digestive HealthKorean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
Fostering collaboration in the field of digestive health.REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.
Annals of Gastroenterology
Connecting Clinicians and Researchers in GastroenterologyAnnals of Gastroenterology, published by the Hellenic Society of Gastroenterology, serves as a pivotal platform for advancing the field of gastroenterology, highlighting research that spans across the spectrum of gastrointestinal diseases and treatments. With an ISSN of 1108-7471 and E-ISSN of 1792-7463, this journal has established itself as a reputable source of scholarship since its inception in 2000, converging valuable insights through to 2024. Ranking within Q2 of its category and achieving a respectable 78th position out of 167 in the Scopus rankings, the journal holds a strong presence in the academic community, appealing to researchers, clinicians, and students alike. Although not an open access publication, Annals of Gastroenterology is dedicated to disseminating high-quality research that aids in the understanding and treatment of gastrointestinal conditions, making it an essential reference point for those engaged in this dynamic field.
DIGESTIVE AND LIVER DISEASE
Advancing knowledge in gastroenterology and hepatology.DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.
WORLD JOURNAL OF GASTROENTEROLOGY
Connecting researchers with groundbreaking findings.WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.
Gastroenterology
Leading the Way in Gastrointestinal Research ExcellenceGastroenterology, published by W B Saunders Co-Elsevier Inc, is a premier journal dedicated to advancing the knowledge and practice within the fields of gastroenterology and hepatology. Established in 1945 and covering a wide range of topics related to digestive health, this journal holds a distinguished position in the academic community, as evidenced by its impressive Q1 status in both Gastroenterology and Hepatology categories, and its high rankings (4th in both disciplines) in Scopus, placing it in the top percentile for scholarly impact. With its commitment to publishing high-quality research, reviews, and clinical studies, Gastroenterology provides an essential resource for researchers, healthcare professionals, and students seeking cutting-edge insights that inform clinical practices and enhance patient care. Although it does not currently offer open access, the journal continues to serve as a vital platform for disseminating meaningful research that shapes the future of digestive disease management.
Pediatric Gastroenterology Hepatology & Nutrition
Transforming knowledge into practice for healthier futures.Pediatric Gastroenterology Hepatology & Nutrition is a pivotal academic journal published by the Korean Society of Pediatric Gastroenterology & Nutrition, focusing on the critical fields of pediatric gastroenterology, hepatology, and nutrition. Located in South Korea, this journal aims to disseminate high-quality research, review articles, and clinical studies to advance knowledge and practice in the care of children with gastrointestinal and nutritional disorders. With a Converged Years span from 2012 to 2024 and categorized in the Q2 and Q3 quartiles in 2023 across multiple related fields, the journal holds a significant position within the academic community, reflecting its impactful contribution to the discipline. Although currently not open access, the journal ensures that content is accessible to a broad audience through various institutional subscriptions. The journal appeals to researchers, healthcare professionals, and students alike, providing an essential platform for the exchange of innovative ideas and research findings aimed at improving pediatric patient care.
Nature Reviews Gastroenterology & Hepatology
Synthesis of Cutting-Edge Research and Clinical InsightsNature Reviews Gastroenterology & Hepatology is a premier academic journal published by NATURE PORTFOLIO, specializing in the vital fields of gastroenterology and hepatology. With an impressive impact factor and categorized in Q1 for both disciplines, this journal ranks at the top of its field, with Scopus rankings placing it in the 99th percentile for gastroenterology and hepatology. The journal aims to provide critical reviews that synthesize the latest research findings, clinical practices, and breakthroughs, catering to researchers, healthcare professionals, and students alike. With its wide-ranging access options, it promotes the dissemination of knowledge essential for advancements in understanding digestive and liver disorders. The journal has been committed to academic excellence since its convergence in 2009, continuing to shape the future of gastroenterological and hepatological research through rigorous peer-reviewed content.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Uncovering the latest in digestive health advancements.Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.
Gastroenterologia y Hepatologia
Bridging research and practice in gastroenterology and hepatology.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.